A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Healthpeak Properties has written down the value of its Point Grand complex in South San Francisco by nearly $170 million.

The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...

The total market value of ALL pharma and biotech companies is $4.6 trillion.

Health Biotech Limited (Health Biotech), a research and development-driven pharmaceutical company from India, successfully ...

Earlier, President Trump stated that companies without factories in the U.S. would face 100% tariffs on their pharmaceuticals ...

Advisers, some employees and some board members are scoring payouts ranging from $75,000 to $53 million.

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...